MAP Health Management sells Software as a Service (SAAS) to treatment providers, who use the technology to demonstrate outcomes. It is not related to the initiative by the National Association of Addiction Treatment Providers (NAATP), which is a long-term research study of outcomes from multiple treatment providers (see ADAW, May 16). Rather, it is focused on the outcomes insurance companies want to see, according to CEO Jacob Levenson.

“I get calls from people all the time asking what are the outcomes to track,” Levenson told ADAW in an interview about MAP last week. “I say to track the ones that payers will reimburse.”

What payers want

MAP’s service is not research; it’s a product. But Levenson thinks there’s a need for something commercial. “Personally, I put a lot more weight on the outcomes that are driving reimbursement,” Levenson said. “This whole industry is moving from a fee-for-service reimbursement model to a quality-based value-driven model.”

“Telehealth” is one service that is going to be increasingly important, said Levenson. By contacting patients who were discharged from residential treatment, for example, a treatment provider can monitor continued recovery. And technology can make this monitoring simpler — not only does it help gauge individual patients, but the data can be collected and aggregated to show success rates. Telehealth is also reimbursable in many states as a form of case management, said Levenson.

Through telehealth, MAP can assess the risk of relapse. “We can understand who is at risk and for what reason, which allows for a precise response to be delivered,” he said. “The end result is an improved outcome.”

Insurance companies are interested in reducing future treatment episodes, which are caused by high rates of relapse, said Levenson. “If we understand who is at risk and what we can do about it, we can reduce costs.”

MAP is working with payers to determine what quality measures to use, said Levenson. “This is what payers understand — something can be measured, and there are tools you can use to measure it,” he said.

“Here’s what is considered a bad outcome by payers — any situation that results in claims,” said Levenson. “That’s the problem we have in this space — we don’t have a common definition of what success means, because success to a payer, to a provider and to a family or patient all mean something different.”

What is a good outcome for treatment? “One hundred percent remission for SUD [substance use disorder] patients is fantastic,” said Levenson. “We can all agree on that.”

Preventing relapse

But actually using data to prevent relapse is tricky. “Data is one thing; actionable data is another,” he said. “What keeps me up at night is how to use this data to both reduce cost and improve quality.”

The best way to reduce cost is early intervention, which also includes intervening when someone in recovery is at risk for relapse. “If we know that someone’s risk profile has reached a critical threshold and that person can be immediately contacted, what can we do to take action — that’s what we need to focus on,” he said.

Levenson declined to share what MAP costs are to providers. “It depends, because different providers need different solutions,” he said. “It’s not software that comes out of a box. Software is just a tool. The value comes when outcomes are improved.”

So far, 90 treatment programs have signed up for MAP.


One of MAP’s clients is Young People in Recovery (YPR), which is providing recovery coach services to some treatment providers and wants to be able to show that these services are valuable, said Levenson. “YPR said they want to understand the value of the services they provide, and they need the technology that enables better case management in outcomes reporting,” he said.

YPR announced last spring that it is offering proprietary programs, the first of which is “My Recovery is E.P.I.C.” (for Engaged, Peer-driven, Integrated and Community). The program provides support for patients in treatment for a substance use disorder, as well as aftercare. “We took a look at addiction treatment practices and asked what we could do to enhance the experience and help more young people maintain long-term recovery,” said Justin Luke Riley, CEO of YPR, in announcing the program. “By teaming with MAP, we will empower our chapters with a population health management platform that collects, measures and demonstrates the data needed to track the efficacy of addiction treatment.